PHARMA-BIO SERV, INC. Proceeds from Sale and Maturity of Marketable Securities
PHARMA-BIO SERV, INC. (PBSV) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 12-month period ending 2020-10-31, per its 10-K filed 2021-02-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2021-02-01
- PHARMA-BIO SERV, INC. proceeds from sale and maturity of marketable securities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- PHARMA-BIO SERV, INC. proceeds from sale and maturity of marketable securities for fiscal 2019 was $44.48K.
- PHARMA-BIO SERV, INC. proceeds from sale and maturity of marketable securities for fiscal 2018 was $0.00.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|
| 2020-10-31 | $0.00 10-K · filed 2021-02-01 |
| 2019-10-31 | $44.48K 10-K · filed 2021-02-01 |
| 2018-10-31 | $0.00 10-K · filed 2020-01-29 |